Literature DB >> 29342293

Genetic Analyses in Small-for-Gestational-Age Newborns.

Susanne E Stalman1,2, Nita Solanky2, Miho Ishida2, Cristina Alemán-Charlet2, Sayeda Abu-Amero2, Marielle Alders3, Lucas Alvizi4, William Baird2, Charalambos Demetriou2, Peter Henneman3, Chela James5, Lia C Knegt3, Lydia J Leon2, Marcel M A M Mannens3, Adi N Mul3, Nicole A Nibbering3, Emma Peskett2, Faisal I Rezwan6, Carrie Ris-Stalpers7, Joris A M van der Post7, Gerdine A Kamp8, Frans B Plötz8, Jan M Wit9, Philip Stanier2, Gudrun E Moore2, Raoul C Hennekam1.   

Abstract

Context: Small for gestational age (SGA) can be the result of fetal growth restriction, which is associated with perinatal morbidity and mortality. Mechanisms that control prenatal growth are poorly understood. Objective: The aim of the current study was to gain more insight into prenatal growth failure and determine an effective diagnostic approach in SGA newborns. We hypothesized that one or more copy number variations (CNVs) and disturbed methylation and sequence variants may be present in genes associated with fetal growth. Design: A prospective cohort study of subjects with a low birth weight for gestational age. Setting: The study was conducted at an academic pediatric research institute. Patients: A total of 21 SGA newborns with a mean birth weight below the first centile and a control cohort of 24 appropriate-for-gestational-age newborns were studied. Interventions: Array comparative genomic hybridization, genome-wide methylation studies, and exome sequencing were performed. Main Outcome Measures: The numbers of CNVs, methylation disturbances, and sequence variants.
Results: The genetic analyses demonstrated three CNVs, one systematically disturbed methylation pattern, and one sequence variant explaining SGA. Additional methylation disturbances and sequence variants were present in 20 patients. In 19 patients, multiple abnormalities were found.
Conclusion: Our results confirm the influence of a large number of mechanisms explaining dysregulation of fetal growth. We concluded that CNVs, methylation disturbances, and sequence variants all contribute to prenatal growth failure. These genetic workups can be an effective diagnostic approach in SGA newborns.

Entities:  

Mesh:

Year:  2018        PMID: 29342293     DOI: 10.1210/jc.2017-01843

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Epigenetics Beyond Fetal Growth Restriction: A Comprehensive Overview.

Authors:  Noemi Salmeri; Ilma Floriana Carbone; Paolo Ivo Cavoretto; Antonio Farina; Danila Morano
Journal:  Mol Diagn Ther       Date:  2022-08-26       Impact factor: 4.476

2.  Risk Factors for Short Stature in Children Born Small for Gestational Age at Full-Term.

Authors:  Lan Ling; Ting Chen; Xin-Hua Zhang; Min-Hong Pan; Hai-Hong Gong; Li-Na Zhang; Meng Zhao; Xiao-Qing Chen; Shu-Dong Cui; Chao Lu
Journal:  Front Pediatr       Date:  2022-06-22       Impact factor: 3.569

3.  Exosomal miRNA Profile in Small-for-Gestational-Age Children: A Potential Biomarker for Catch-Up Growth.

Authors:  Hwal Rim Jeong; Jae-A Han; Heeji Kim; Hye Jin Lee; Young Suk Shim; Min Jae Kang; Jong Seo Yoon; Seongho Ryu; Il Tae Hwang
Journal:  Genes (Basel)       Date:  2022-05-24       Impact factor: 4.141

4.  Genetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study.

Authors:  Su-Jung Park; Narae Lee; Seong-Hee Jeong; Mun-Hui Jeong; Shin-Yun Byun; Kyung-Hee Park
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

5.  Intrauterine Twin Discordancy and Partial Postnatal Catch-up Growth in a Girl with a Pathogenic IGF1R Mutation

Authors:  Paula Ocaranza; Monique Losekoot; Marie J. E. Walenkamp; Christiaan De Bruin; Jan M. Wit; Veronica Mericq
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-03-12

6.  Role of Imprinting Disorders in Short Children Born SGA and Silver-Russell Syndrome Spectrum.

Authors:  Tomoko Fuke; Akie Nakamura; Takanobu Inoue; Sayaka Kawashima; Kaori Isono Hara; Keiko Matsubara; Shinichiro Sano; Kazuki Yamazawa; Maki Fukami; Tsutomu Ogata; Masayo Kagami
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

7.  Prevalence of copy number variants (CNVs) and rhGH treatment efficacy in an Italian cohort of children born small for gestational age (SGA) with persistent short stature associated with a complex clinical phenotype.

Authors:  E Inzaghi; A Deodati; S Loddo; M Mucciolo; F Verdecchia; E Sallicandro; G Catino; M Cappa; A Novelli; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2021-07-13       Impact factor: 4.256

Review 8.  Genetic Screening for Growth Hormone Therapy in Children Small for Gestational Age: So Much to Consider, Still Much to Discover.

Authors:  Claudio Giacomozzi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

9.  Analysis of CDKN1C in fetal growth restriction and pregnancy loss.

Authors:  Jenifer P Suntharalingham; Miho Ishida; Gudrun E Moore; John C Achermann; Federica Buonocore; Ignacio Del Valle; Nita Solanky; Charalambos Demetriou; Lesley Regan
Journal:  F1000Res       Date:  2019-01-23

10.  Gene Variants Determine Placental Transfer of Perfluoroalkyl Substances (PFAS), Mercury (Hg) and Lead (Pb), and Birth Outcome: Findings From the UmMuKi Bratislava-Vienna Study.

Authors:  Claudia Gundacker; Klaudia Graf-Rohrmeister; Martin Gencik; Markus Hengstschläger; Karol Holoman; Petra Rosa; Renate Kroismayr; Ivo Offenthaler; Veronika Plichta; Theresa Reischer; Isabella Teufl; Wolfgang Raffesberg; Sigrid Scharf; Birgit Köhler-Vallant; Zoja Delissen; Stefan Weiß; Maria Uhl
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.